Please wait a minute...
Reviews in Cardiovascular Medicine  2014, Vol. 15 Issue (4): 320-331     DOI: 10.3909/ricm0724
Review Previous articles | Next articles
Why Currently Used Diagnostic Techniques for Heart Failure in Rheumatoid Arthritis Are Not Enough: The Challenge of Cardiovascular Magnetic Resonance Imaging
Sophie Mavrogeni1, Theodoros Dimitroulas2, Sherine Gabriel3, Petros P. Sfikakis4, Gerald M. Pohost5, George D. Kitas6
1 Onassis Cardiac Surgery Center, Athens, Greece
2 Department of Rheumatology, Russells Hall Hospital, West Midlands, United Kingdom
3 Department of Health Sciences Research and Division of Rheumatology, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN
4 First Department of Propaedeutic and Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece
5 Keck School of Medicine, University of Southern California, Los Angeles, CA, Loma Linda University, Loma Linda, CA, Westside Medical Imaging, Beverly Hills, CA
6 Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom
Download:  PDF(343KB)  ( 170 )
Export:  BibTeX | EndNote (RIS)      
Rheumatoid arthritis (RA) is a multiorgan inflammatory disorder affecting approximately 1% of the population that leads to progressive joint destruction and disability. Patients with RA exhibit a high risk of cardiovascular disease, which results in premature morbidity and mortality and reduced life expectancy, when compared with the general population. Among various guises of myocardial involvement, heart failure (HF) has been recently recognized as an important contributory factor to the excess cardiovascular mortality associated with RA. HF in RA typically presents with occult clinical symptomatology and is mainly associated with structural and functional left ventricular abnormalities leading to diastolic dysfunction, while systolic myocardial performance remains well preserved. As isolated diastolic dysfunction is a predictor of high mortality, the evaluation of patients in early asymptomatic stages, when treatment targeting the heart is more likely to be effective, is of great importance. Although patient history and physical examination remain the cornerstones of HF evaluation, noninvasive imaging of cardiac chambers, coronary arteries, and great vessels may be necessary. Echocardiography, nuclear techniques, and invasive coronary angiography are already established in the routine assessment of HF; however, many aspects of HF pathophysiology in RA remain obscure, due to the limitations of currently used techniques. The capability of cardiovascular magnetic resonance (CMR) to capture early tissue changes allows timely detection of pathophysiologic phenomena of HF in RA, such as myocardial inflammation and myocardial perfusion defects, due to either macrovascular (coronary artery disease) or microvascular (vasculitis) disease. Therefore, CMR may be a useful tool for early, accurate diagnosis and research in patients with RA.
Key words:  Rheumatoid arthritis      Myocarditis      Vasculitis      Coronary artery disease      Heart failure      Echocardiography      Nuclear cardiology      Computed tomography      Cardiac magnetic resonance     
Published:  30 December 2014     

Cite this article: 

Sophie Mavrogeni, Theodoros Dimitroulas, Sherine Gabriel, Petros P. Sfikakis, Gerald M. Pohost, George D. Kitas. Why Currently Used Diagnostic Techniques for Heart Failure in Rheumatoid Arthritis Are Not Enough: The Challenge of Cardiovascular Magnetic Resonance Imaging. Reviews in Cardiovascular Medicine, 2014, 15(4): 320-331.

URL:     OR

[1] Meer Fakhry, Mandeep S. Sidhu, Sripal Bangalore, Roy O. Mathew. Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 157-162.
[2] Anthony (Ming-yu) Chuang, Mau T Nguyen, Woon-Man Kung, Sam Lehman, Derek P Chew. High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 191-203.
[3] Matteo Cameli, Maria Concetta Pastore, Michael Henein, Hatem Soliman Aboumarie, Giulia Elena Mandoli, Flavio D'Ascenzi, Paolo Cameli, Federico Franchi, Sergio Mondillo, Serafina Valente. Safe performance of echocardiography during the COVID-19 pandemic: a practical guide[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 217-223.
[4] Chiara Minà, Laura Ajello, Gabriele Di Gesaro, Calogero Falletta, Francesco Clemenza. Hyperkalemia in heart failure: current treatment and new therapeutic perspectives[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 241-252.
[5] Zhanru Qi, Hongyan Zheng, Zhonghai Wei, Qing Dai, Jun Xie, Lian Wang, Jingmei Zhang, Jie Song. Short-term and long-term outcomes of bailout versus planned coronary rotational atherectomy[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 309-314.
[6] Amir Kazory, Maria Rosa Costanzo. The dynamic relationship between serum chloride and cardiorenal syndrome[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 25-29.
[7] Megan S. Joseph, Maryse Palardy, Nicole M. Bhave. Management of heart failure in patients with end-stage kidney disease on maintenance dialysis: a practical guide[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 31-39.
[8] Guicheng Liang, Beizhu Xu, Shirong Wang, Chengxuan Li, Guoqiang Zhong. Imaging with intracardiac echocardiography compared to transesophageal echocardiography during left atrial appendage occlusion[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 93-101.
[9] Xiaogen Chen, Chunna Jin, Lan Xie, Meixiang Xiang. LCZ696 and preservation of renal function in heart failure: A meta-analysis of 6 randomized trials[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 113-118.
[10] Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 123-127.
[11] Yuhong Liu, Zhihuan Zeng, Xing Yu, Tudi Li, Yusi Yao, Rong Chen, Jianyi Zheng. Impact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 147-153.
[12] Hesam Mostafavi Toroghi, Kevin Bryan Lo, Mary Rodriguez Ziccardi, Benjamin Horn, Napatt Kanjanahattakij, Erum Malik, Jorge Penalver, Janani Rangaswami, Shuchita Gupta, Aman Amanullah. Renal implications of pulmonary arterial capacitance in acute heart failure with preserved ejection fraction[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 267-272.
[13] Girish Singhania, Abutaleb A. Ejaz, Peter A. McCullough, Aaron Y. Kluger, Saravanan Balamuthusamy, Bhagwan Dass, Namrata Singhania, Adhish Agarwal. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 111-120.
[14] Victoria E. Tril, Alla V. Burlutskaya, Lily V. Polischuk. Metabolic cardiomyopathy in pediatrics[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 73-80.
[15] Sofia A. Horvath, Nicholas Suraci, Jayanand D'Mello, Orlando Santana. Persistent left superior vena cava identified by transesophageal echocardiography[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 99-100.
No Suggested Reading articles found!